Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif

Bioorganic & Medicinal Chemistry
2014.0

Abstract

A series of 1,3,4-thiadiazole-containing hydroxamic acids, in accord with the common pharmacophore of histone deacetylase (HDAC) inhibitors (a Zn(2+) binding moiety-a linker-a surface recognition motif), was identified as submicromolar HDAC inhibitors by our group. In this study, we continued our efforts to develop 1,3,4-thiadiazole bearing hydroxamate analogues by modifying the surface recognition motif. We found that 1,3,4-thiadiazoles having a heteroaromatic substituent showed better HDAC inhibitory activity in enzymatic assay and higher antiproliferative potency in cellular assay compared to SAHA.

Knowledge Graph

Similar Paper

Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif
Bioorganic & Medicinal Chemistry 2014.0
2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: Design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry 2014.0
Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1 H -pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study
Bioorganic & Medicinal Chemistry Letters 2016.0
Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry 2016.0
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
Journal of Medicinal Chemistry 2014.0
Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group
Bioorganic & Medicinal Chemistry 2008.0
Trithiocarbonates—Exploration of a new head group for HDAC inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0